NEW DOUBLE ACTION RECEIVERS (DARA) ANTAGONISTS FOR AT1 ETA RECEPTORS

摘要

NEW DOUBLE ACTION RECEPTOR ANTAGONISTS (DARA) FOR ATi AND ETA RECEPTORS The present invention relates to new compounds of the formula: where R1, R2, R3 and R31 are as specified here. The invention also refers to a method for preparing them, as well as combinations of the new compounds with previously known agents. The invention also relates to the use of the compounds and combinations mentioned above for the preparation of a medicament for the treatment of hypertension of different types, relief of damage to organs of different types, treatment or prevention of diabetic nephropathy, treatment of endothelin-mediated disorders and angiotensin, and treatment of prostate cancer.